Cardiovascular

Latest News

Anjali Vaidya, MD, FACC, FASE, FACP | Image Credit: Temple University Hospital

Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD

By Maggie L. Shaw
Anjali Vaidya, MD, FACC, FASE, FACP

September 17th 2025

New findings reveal sotatercept's significant benefits for right ventricular function and tricuspid regurgitation in pulmonary arterial hypertension.

Women holding up heart hands | Image credit: Studio Romantic – stock.adobe.com

Women Still Underrepresented in Key Cardiovascular Trials

By Hayden E. Klein

September 11th 2025

Empagliflozin bottle | Image credit: luchschenF – stock.adobe.com

Empagliflozin Shown to Reduce Endothelial Dysfunction in Women With INOCA

By Hayden E. Klein

September 10th 2025

FDA approved. | Image Credit: Pawel - stock.adobe.com

FDA Expands Evolocumab Label for Adults With Increased MACE Risk From Uncontrolled LDL-C

By Hayden E. Klein

August 25th 2025

Women are at a higher risk for developing cardiovascular disease or experiencing an adverse cardiovascular disease event if they've been stalked or obtained a restraining order. | Image Credit: AdobeStock_Joerch.jpeg

Stalking Associated With Higher Risk of CVD in Women

By Sabrina McCrear

August 13th 2025

Lipoprotein(a) and Cardiovascular Risk

Learn about more about lipoprotein(a), including how to improve patient outcomes through better screening and management.

Watch Now

Continuing Medical Education

View All

September 17th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

September 17th 2025

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology

September 17th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

September 17th 2025

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

1.5 Credits / Cardiology

September 17th 2025

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

1.5 Credits / Cardiology, Rare Diseases

September 17th 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

December 18th 2017

As Trials Report Cardiovascular Outcomes Data, What About Microvascular Results?

Andrew Smith

Evidence is more robust on kidney function but not sufficient to make drug decisions, one expert said. A whole separate trial, called CREDENCE, is examining renal function in patients taking canagliflozin.

December 17th 2017

Dr Amar Bhakta Explains a New Pathway to Prevent Heart Failure Readmissions

A new pathway uses a multidisciplinary team to help reduce 30-day heart failure readmissions, explained Amar Bhakta, MD, of Rush University Medical Center.

December 14th 2017

For Those With Diabetes and CV Risk, Personalized Care Matters

Robert A. Gabbay, MD, PhD, FACP

From the Editor in Chief

December 13th 2017

MGH: Centralized population health coordinators help improve care for patients with chronic disease

December 8th 2017

AJMC® in the Press, December 8, 2017

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

December 5th 2017

Dr Todd Hobbs Discusses the Advantages of Semaglutide in Type 2 Diabetes

On December 5, 2017, FDA approved Novo Nordisk’s semaglutide, a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of type 2 diabetes. Todd Hobbs, MD, Novo Nordisk’s vice president and chief medical officer, spoke with The American Journal of Managed Care® just ahead of FDA’s action.

December 5th 2017

Targeting Lipids May Improve Outcomes of Abdominal Aortic Aneurysm

Laura Joszt, MA

Abdominal aortic aneurysm is a cardiovascular disease for which 45,000 operations are performed yearly in the United States, but a new study found that targeting lipids may improve long-term outcomes.

December 1st 2017

AJMC® in the Press, December 1, 2017

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

December 1st 2017

Dr Eliot A. Brinton: Perspectives on PCSK9 Inhibitors

Results from the FOURIER trial have provided convincing data that there is no downside to aggressively lowering cholesterol with PCSK9 inhibitors, and studies have shown there are cardiovascular benefits associated with Repatha, but reimbursement remains challenging, said Eliot A. Brinton, MD, FAHA, FNLA, president of the Utah Lipid Center.

November 29th 2017

Any Physical Activity Lowers CVD Risk for Elderly, Study Finds

Jaime Rosenberg

Physical activity, even of a low-intensity, reduces the risk of cardiovascular disease in older adults, according to a study published in The European Journal of Preventive Cardiology. Although the authors found similar associations for individuals under age 55 and individuals aged 55-65, the results were not statistically significant.

November 27th 2017

Cardiovascular Screenings Increase After the ACA, Study in The American Journal of Managed Care® Finds

Physicians’ response to policy changes in the Affordable Care Act show that changing cost-sharing formulas can make a difference, according to results reported by Drs. Joseph Ladapo and Dave Chokshi.

November 23rd 2017

Systolic Blood Pressure of 140 mm Hg or Higher Should Be Treated to Prevent Death and CVD

Jaime Rosenberg

A study published in JAMA Internal Medicine found that blood pressure (BP) lowering is associated with reduced risk of death and cardiovascular disease (CVD) if the baseline systolic blood pressure (SBP) is 140 mm Hg or higher. Treatment may be considered in patients with coronary heart disease and SBP under 140 mm Hg, but not for primary prevention.

November 20th 2017

Changes in Cardiovascular Care Provision After the Affordable Care Act

Joseph A. Ladapo, MD, PhD Dave A. Chokshi, MD, MSc

The authors evaluated whether the 2010 Affordable Care Act was associated with changes in physicians’ provision of preventive cardiovascular services.

November 18th 2017

Dr Justin Bachmann: Challenges of Implementing Behavioral Interventions in Cardiac Care

The biggest challenge of implementing behavioral interventions to improve care for patients with cardiovascular disease is reimbursement models, said Justin Bachmann, MD, MPH, FACC, Cardiologist and Clinical Investigator, Instructor of Medicine and Health Policy, Vanderbilt University Medical Center.

November 15th 2017

Xarelto Plus Aspirin: Based on COMPASS, It Cuts Costs

Mary Caffrey

The analysis presented at the American Heart Association looks strictly at healthcare costs, but a broader cost-effectiveness study is planned that will consider drug costs as well as effect on patient quality of life.

November 15th 2017

Researchers Dig Deeper on SGLT2 Inhibitors and Find Plenty of News

Mary Caffrey

Researchers presenting at the American Heart Association look at specific populations within 2 large diabetes drug trials, CANVAS and EMPA-REG OUTCOME.

November 9th 2017

Dr John Rumsfeld: We're Just at the Beginning of the Digital Health Transformation

Digital health, artificial intelligence and machine learning, and precision medicine are the areas where there is the most excitement in innovations for cardiovascular care, said John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology.

November 7th 2017

Rheumatology Patients at Increased Risk for Cardiac Disease

Kelly Davio

During a session at the 2017 American College of Rheumatology Annual Meeting in San Diego, California, a cardiologist joined rheumatologists to give a detailed look at the relationship between rheumatic conditions and cardiovascular disease.

November 4th 2017

Christi Deaton: Challenges of Motivating Patients to Participate in CVD Prevention Strategies

The biggest challenges in promoting cardiovascular prevention strategies is motivating people to change a lifetime of poor habits into healthier habits, explained Christi Deaton, PhD, RN, FAHA, FESC, of the University of Cambridge.

October 24th 2017

Dr John Rumsfeld on the Digital Transformation of Cardiovascular Medicine

The digital transformation of the cardiology field in the coming years will have a huge impact on the delivery of healthcare, said John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology.

October 23rd 2017

Teens Are Sleeping Less, and Smartphones Are Blamed

Mary Caffrey

The authors find that sleep in teens fell after 2009, as smartphone use escalated. Lack of sleep has been linked to insulin resistance.

October 13th 2017

Countywide Physician Organization Learning Collaborative and Changes in Hospitalization Rates

Brent D. Fulton, PhD, MBA Susan L. Ivey, MD, MHSA Hector P. Rodriguez, PhD, MPH Stephen M. Shortell, PhD, MPH, MBA

The University of Best Practices physician organization learning collaborative in San Diego County was associated with lower hospitalization rates for heart attacks.

October 12th 2017

Higher Physical Activity Lowers Risk of Mortality and Cardiovascular Disease

Jaime Rosenberg

A study has found that both recreational and non-recreational activity reduces the risk of mortality and cardiovascular disease, regardless of the country's economic status.

October 11th 2017

Lower LDL Cholesterol Associated With Higher Mortality in American Indians

Laura Joszt, MA

Excessively low levels of low-density lipoprotein cholesterol and triglycerides is associated with a higher all-cause mortality among American Indians, according to a new study published online ahead of print in Journal of Diabetes and Its Complications.

October 3rd 2017

Dr Simon Gibbs Discusses the Future of Pulmonary Hypertension Treatments

Current drugs for pulmonary hypertension treat 3 pathways, but currently there aren't any new drugs to treat different pathways, although there likely will be some in the future, said Simon Gibbs, MD, Reader in Pulmonary Hypertension at the National Heart and Lung Institute, Imperial College London.

October 1st 2017

Dr Steven Nissen Argues for Aggressively Lowering LDL Cholesterol

There is an ongoing debate about how aggressively to lower low-density lipoprotein (LDL) cholesterol, but Steve Nissen, MD, of Cleveland Clinic, argues that studies have shown an aggressive approach to lowering LDL always shows benefits.

September 18th 2017

Early Trauma, Depression, and the Need for Social Connection

Mary Caffrey

Experts said that the frequency and quality of social relationships have a greater effect on mortality than obesity or drinking alcohol, and this commands attention from health systems.

September 15th 2017

5 Facts About Air Pollution's Impact on Health

Laura Joszt, MA

In the wake of Hurricane Harvey, Houston is expected to face a host of health challenges, including air pollution. Here are 5 facts about how air pollution affects people’s health.

September 13th 2017

Statin Drug Use in COPD Patients Linked to Mortality Reductions

Alison Rodriguez

The use of statin drugs in patients with chronic obstructive pulmonary disease is associated with benefits including decreased lung-related and all-cause mortality, according to a research.

September 7th 2017

Dr Jeanette Stingone on Lasting Cardiovascular Effects of Prenatal Exposure to Air Pollution

Researchers have known for years: what happens to mom in pregnancy affects the baby. That holds true with prenatal exposure to air pollution, which has lingering cardiovascular effects, such as birth defects and a higher risk of obesity, explained Jeanette Stingone, PhD, of Mount Sinai Health System.

...

11 12 13 14 15 16 17 18 19

...

25 >

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

Do Not Sell My Information

Terms & Conditions